Express-Scripts, Medco merger OK appears closer
Brushing aside opposition from Congress, states’ attorneys general and pharmacists’ groups, the FTC appears unlikely to block the controversial $29 billion merger of mega-prescription benefit managers Express- Scripts Inc. and Medco...To view the full article, register now.
Already a subscriber? Click here to view full article